Syneron Medical Ltd's recently introduced LipoLite laser-assisted lipolysis device this week received FDA clearance for laser-assisted lipolysis and additional dermatological procedures.
LipoLite features OptiPulse technology, which optimizes the mechanical breakdown of target tissue and the thermal destruction of fat cell membranes during procedures. OptiPulse utilizes two unique pulse energy levels and pulse repetition rates to provide physicians with precise control.
"During clinical trials, the treatment provided good results with minimal pain," said Stephen Mulholland, MD, board-certified plastic surgeon and medical director of SpaMedica in Toronto. "For many of the trial participants, pairing LipoLite laser lipolysis with VelaShape follow up procedures was the ideal combination for a minimally invasive treatments leading to body shaping."
According to the American Society of Aesthetic Plastic Surgery, the number of liposuction procedures increased 158% from 1997 to 2007. With more than 450,000 procedures performed in 2007, liposuction was the most frequently performed surgical cosmetic procedure last year.
[Source: Syneron Medical Ltd]
